Supreme Court Directs Government to Formulate Policy for Covid Vaccine Adverse Events

The Supreme Court's directive is rooted in India's constitutional framework. Article 21 (Right to Life and Personal Liberty) has been interpreted to include the right to health, making it the state's fundamental responsibility to protect citizens' well-being. Article 47 (Directive Principles of State Policy - DPSP) mandates the State to improve public health as a primary duty. For Prelims, the key distinction is that Article 21 is a Fundamental Right, directly enforceable by courts, while Article 47 is a DPSP, which are fundamental in the governance of the country but not directly enforceable.

The Supreme Court's directive came in response to multiple petitions filed by families who suffered severe injuries or deaths following Covid-19 vaccination. These families were seeking relief and accountability for vaccine-related complications. The Court's action underscores its role in ensuring state accountability and redressal mechanisms, especially when existing systems might be perceived as inadequate or inaccessible for citizens facing adverse events.

Formulating such a policy presents several challenges and benefits.Challenges include:1. Defining 'adverse events' clearly and establishing a causal link to vaccination.2. Ensuring adequate funding for compensation without burdening the exchequer excessively.3. Creating a transparent and accessible application and review process for affected individuals.4. Balancing public trust in vaccines with accountability for rare adverse events.Potential benefits are:1. Enhancing public trust in future vaccination programs by assuring a safety net.2. Providing timely and fair compensation to affected families, upholding the right to health.3. Establishing a clear legal and administrative framework for accountability.4. Aligning India with global best practices, as many countries have Vaccine Injury Compensation Programs (VICP).

• •Defining 'adverse events' clearly and establishing a causal link to vaccination.
• •Ensuring adequate funding for compensation without burdening the exchequer excessively.
• •Creating a transparent and accessible application and review process for affected individuals.
• •Balancing public trust in vaccines with accountability for rare adverse events.

An 'Adverse Event Following Immunization (AEFI)' is any untoward medical occurrence that follows immunization and does not necessarily have a causal relationship with the vaccine. India's current system primarily relies on an AEFI surveillance system, which focuses on monitoring and investigating these events to ensure vaccine safety. In contrast, a 'Vaccine Injury Compensation Program (VICP)' is a 'no-fault' compensation scheme established in several countries. It provides financial compensation to individuals injured by vaccines without requiring them to prove fault or negligence against the vaccine manufacturer or administrator. India currently lacks a dedicated VICP, which is what the Supreme Court's directive aims to address.

This directive could significantly impact future public health campaigns. On one hand, establishing a clear compensation policy could boost public confidence in vaccination drives, as citizens would know there's a safety net for rare adverse events. This might encourage higher vaccine uptake. On the other hand, it could also increase scrutiny on vaccine safety and the government's responsibility, potentially leading to more legal challenges if the policy is not robustly implemented. It emphasizes the need for comprehensive pre-campaign planning that includes not just vaccine delivery but also robust post-vaccination care and redressal mechanisms.

Following the Supreme Court's directive, the Union government is now mandated to formulate a comprehensive, transparent, and accessible policy for addressing and compensating individuals who suffer adverse events. UPSC aspirants should watch for:1. The specific details of the policy: What criteria will be used to define adverse events? What will be the compensation structure?2. The timeline for implementation: How quickly will the government draft and operationalize this policy?3. The administrative mechanism: Which body or department will be responsible for processing claims and disbursing compensation?4. Any legislative backing: Will this policy be implemented through executive order or require new legislation?These details will be crucial for understanding the practical implications and potential challenges.

• •The specific details of the policy: What criteria will be used to define adverse events? What will be the compensation structure?
• •The timeline for implementation: How quickly will the government draft and operationalize this policy?
• •The administrative mechanism: Which body or department will be responsible for processing claims and disbursing compensation?
• •Any legislative backing: Will this policy be implemented through executive order or require new legislation?